As of November 2024 Sonnet BioTherapeutics Holdings has 1.04M shares outstanding, a increase of 425.77% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 1.04M | 425.77% |
2022 | 197.46K | 147.76% |
2021 | 79.70K | 160.58% |
2020 | 30.59K | - |